| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AT-406 | CTRPv2 | pan-cancer | AAC | 0.0018 | 1 |
| mRNA | istradefylline | CTRPv2 | pan-cancer | AAC | -0.0018 | 1 |
| mRNA | Gefitinib | FIMM | pan-cancer | AAC | 0.0045 | 1 |
| mRNA | ETP-46464 | CTRPv2 | pan-cancer | AAC | -0.0012 | 1 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.0013 | 1 |
| mRNA | AZD-2281 | FIMM | pan-cancer | AAC | 0.0043 | 1 |
| mRNA | shikonin | GDSC1000 | pan-cancer | AAC | 0.00082 | 1 |
| mRNA | Tipifarnib | GDSC1000 | pan-cancer | AAC | 0.00069 | 1 |
| mRNA | CBB-1007 | CTRPv2 | pan-cancer | AAC | -0.0011 | 1 |
| mRNA | navitoclax:piperlongumine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0007 | 1 |